Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Switching ART in a Heavily Treatment–Experienced Patient With HIV

In this call between colleagues, expert faculty discuss how they approach ART optimization in a virologically suppressed patient with HIV and multiclass resistance, including a discussion of relevant guidelines and data.
Roger Bedimo, MD, MS, FACP
David A. Wohl, MD
Released: March 24, 2021 Expiration: No longer available for credit

Related Content

Clinical Care Options (CCO) presents patient advocate and patient discussing the importance of overcoming local barriers to HIV care for women

person default Angelina Namiba Released: August 5, 2022

Safety and efficacy of broadly neutralizing antibody VRC01 with early ART in infants with HIV, reported by Clinical Care Options (CCO) from AIDS 2022

Released: August 5, 2022

Safety and efficacy of 24-wk oral regimens for pulmonary rifampicin-resistant TB in persons with HIV, reported by Clinical Care Options (CCO) from AIDS 2022

Released: August 4, 2022

Efficacy of doxycycline PEP for prevention of STIs in MSM and TGW in the DoxyPEP study, reported by Clinical Care Options (CCO) from AIDS 2022

Released: August 4, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Educational grant provided by:
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings